Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis
…, J Genest, SD Shan, RL Reel, JM Albaum… - BMJ open, 2017 - bmjopen.bmj.com
Objectives Heterozygous familial hypercholesterolaemia (FH) confers a significant risk for
premature cardiovascular disease (CVD). However, the estimated prevalence of FH varies …
premature cardiovascular disease (CVD). However, the estimated prevalence of FH varies …
Osteoporosis management among chronic glucocorticoid users: a systematic review
JM Albaum, S Youn, LE Lévesque, AS Gershon… - Journal of population …, 2014 - jptcp.com
Background Clinical practice guidelines recommend that all patients starting chronic oral
glucocorticoid (GC) therapy receive bone mineral density (BMD) testing and osteoporosis …
glucocorticoid (GC) therapy receive bone mineral density (BMD) testing and osteoporosis …
What Is the Risk of Postoperative Neurologic Symptoms After Regional Anesthesia in Upper Extremity Surgery? A Systematic Review and Meta-analysis of …
Background The risk of neurologic symptoms after regional anesthesia in orthopaedic surgery
is estimated to approach 3%, with long-term deficits affecting 2 to 4 per 10,000 patients. …
is estimated to approach 3%, with long-term deficits affecting 2 to 4 per 10,000 patients. …
Persistent high non-high-density lipoprotein cholesterol in early childhood: a latent class growth model analysis
… Author links open overlay panel Jordan M. Albaum MSc 1 2 3 , Sarah Carsley MSc 1 3 4 ,
Yang Chen MA, MSc 5 , David WH Dai MSc 5 , Gerald Lebovic PhD 4 5 , Brian W. McCrindle …
Yang Chen MA, MSc 5 , David WH Dai MSc 5 , Gerald Lebovic PhD 4 5 , Brian W. McCrindle …
Patterns of use for brand-name versus generic oral bisphosphonate drugs in Ontario over a 13-year period: a descriptive study
Background Bisphosphonates are the first-line therapy for the treatment of osteoporosis. In
the province of Ontario, the Ontario Drug Benefit Program funds medications for patients aged …
the province of Ontario, the Ontario Drug Benefit Program funds medications for patients aged …
Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996–2012
JM Albaum, LE Levesque, AS Gershon, G Liu… - Osteoporosis …, 2015 - Springer
We identified that glucocorticoid-induced osteoporosis management (bone mineral density
testing or osteoporosis treatment) among seniors improved among men (2 to 23 %) and …
testing or osteoporosis treatment) among seniors improved among men (2 to 23 %) and …
RICHARD KNILL RESEARCH ORAL COMPETITION
…, G Martin, S Xia, N Timmerman, J Albaum… - 2021 CAS VIRTUAL …, 2021 - Springer
Methods: Ethics approval was not applicable because the study did not involve human or
animal research. Six medical students, three residents and one faculty anesthesiologist have …
animal research. Six medical students, three residents and one faculty anesthesiologist have …
EDUCATION AND SIMULATION IN ANESTHESIA
…, G Martin, S Xia, N Timmerman, J Albaum… - 2021 CAS VIRTUAL …, 2021 - Springer
Methods: Ethics approval was not applicable because the study did not involve human or
animal research. Six medical students, three residents and one faculty anesthesiologist have …
animal research. Six medical students, three residents and one faculty anesthesiologist have …
[CITATION][C] Trends in Glucocorticoid-Induced Osteoporosis Management Among Seniors in Ontario, 1996-2012
JM Albaum, LE Lévesque… - JOURNAL OF …, 2014 - … ST, HOBOKEN 07030-5774, NJ USA
[CITATION][C] Glucocorticoid-induced osteoporosis management: a systematic review
JM Albaum, S Youn… - …, 2013 - … ST, HOBOKEN 07030-5774, NJ USA
